title: An evaluation of the efficacy of aspirin and benzydamine hydrochloride gargle for attenuating postoperative sore throat: a prospective, randomized, single-blind study.
abstract: Postoperative sore throat (POST), although a minor complication, remains a source of postoperative morbidity. We compared the efficacy of dispersible aspirin gargle to benzydamine hydrochloride (a topical nonsteroidal anti inflammatory drug) gargles for prevention of POST. We enrolled 60 consecutive female patients, 16-60 yr of age, ASA physical status I or II, undergoing elective modified radical mastectomy under general anesthesia in this prospective, randomized, placebo-controlled, single-blind study. Patients were randomly divided into 3 groups of 20 subjects each: Group 1 (C) mineral water; Group 2 (AS) tab aspirin 350 mg; and Group 3 (BH) 15 mL of benzydamine hydrochloride (0.15%). All the medications were made into 30 mL of solution. Patients were asked to gargle this mixture for 30 s, 5 min before induction of anesthesia. Grading of POST was done at 0, 2, 4, and 24 h postoperatively on a 4-point scale (0-3). Aspirin gargles reduced the incidence of POST for 4 h whereas benzydamine hydrochloride gargles reduced POST for 24 h. POST was more severe in the control group at 0 and 2 h (P < 0.05). Aspirin and benzydamine hydrochloride gargles significantly reduced the incidence and severity of POST (P < 0.05).
authors.affiliation: Department of Anaesthesiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India. aagarwal@sgpgi.ac.in
authors.forename: Anil
authors.initials: A
authors.lastname: Agarwal
authors.forename: S S
authors.initials: SS
authors.lastname: Nath
authors.forename: Debolina
authors.initials: D
authors.lastname: Goswami
authors.forename: Devendra
authors.initials: D
authors.lastname: Gupta
authors.forename: Sanjay
authors.initials: S
authors.lastname: Dhiraaj
authors.forename: Prabhat K
authors.initials: PK
authors.lastname: Singh
mesh_terms: D000293:Adolescent; D000328:Adult; D000768:Anesthesia, General / Q000009:adverse effects* / Q000379:methods; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage*; D001591:Benzydamine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007442:Intubation, Intratracheal / Q000009:adverse effects*; D008408:Mastectomy; D008875:Middle Aged; D009067:Mouthwashes / Q000008:administration & dosage; D010612:Pharyngitis / Q000209:etiology / Q000517:prevention & control*; D010919:Placebos; D011446:Prospective Studies; D016037:Single-Blind Method
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D009067:Mouthwashes; D010919:Placebos; D001591:Benzydamine; D001241:Aspirin